Selecting the perfect luxe holiday gift for loved ones can sometimes be challenging. This season, Robb Report Editor in Chief, Brett Anderson, suggests looking to brands that have helped shape the trajectory of luxury – those that have withstood the test of time, yet continue to remain both modern and relevant to today’s discerning consumer.
To view the multimedia release go to:
http://www.multivu.com/players/English/7945751-hennessy-x-o-holiday-list/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
Amway North America today launched BODYKEY by NUTRILITE™, a weight management program rooted in genetics that reveals exactly how a person should eat to most effectively manage their weight.
BODYKEY by NUTRILITE weight loss plans are based on an individual’s unique genetic makeup. The new program combines eating well, fitness, nutrition and a take-at-home genetic test to determine if a person’s body responds better to cutting carbs, reducing fat or a balanced diet.
To view Multimedia News Release, go to http://www.multivu.com/players/English/60257-amway-bodykey/
BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, today announced the launch of seven hematology genetics test panels. The new test panels enhance and expand BloodCenter’s genetic testing capability to include a vast array of non-malignant hematology disorders, including platelet function disorders, inherited thrombocytopenia and congenital neutropenias, providing one of the most comprehensive test menus in hematology.
BloodCenter’s integration of functional and genetic testing provides a unique approach to diagnosing complex hematology disorders, providing a comprehensive review of each patient for improved patient care and outcomes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8126851-bloodcenter-of-wisconsin-versiti-hematology-genetics-test-panels/
Beginning today, America can click and choose which Web search results it prefers by participating in the Bing It On Challenge, available at Bing.com. Based on research that indicates people prefer Bing Web search results over Google, Bing is inviting consumers to come and see for themselves with an online test designed to show that the quality of Bing’s Web search results has surpassed Google’s.
Although most people identify themselves as Google searchers, an independent study commissioned by Microsoft Corp. shows people chose Bing Web search results over Google nearly 2-to-1 in blind comparison tests. Given those findings, Bing decided it’s time to let people see for themselves that there is a better option in search.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57699-microsoft-bing-it-on-challenge-web-search-results
Sentetik biyoloji, bilim dünyasında giderek önem kazanmaya başlayan bir alan haline geldi. İngiltere hükümeti de bu alanı öncelikleri arasına aldı. Bu yeni bilim dalı, daha önce doğada varolmayan canlı organizmayı tasarlayıp yaratmayı amaçlıyor. Çalışmayı yürüten bilim insanları, bu sıradışı teknolojiyle yeni yakıt ve ilaç türleri için büyük bir fırsat doğacağı görüşünde. Ancak çevreciler, bu yeni organizmaların doğaya yayılmasının risklerine dikkat çekiyor.
http://www.bbc.co.uk/turkce/multimedya/2012/03/120329_dg_synthetic_biology.shtml
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for the BD Veritor™ System for rapid detection of Flu A+B. This is the first rapid influenza test system that incorporates a digital read out of results to receive CLIA waiver.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53615-bd-veritor-system-influenza-test-receives-510k-clearance-fda-clia-waiver
Two leading golfers, who won Ballantine's Tournaments almost 50 years apart, met at the iconic Wentworth Golf Club to put modern-day golf clubs to the test against equipment first used half a century ago, highlighting the evolution of the game.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/ballantines/40784/
